Cargando…
Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is a complex disease linked to several chronic diseases. We aimed at identifying genetic variants associated with NAFLD and evaluating their functional consequences. We performed a genome-wide meta-analysis of 4 cohorts of electronic health record-documented...
Autores principales: | Ghodsian, Nooshin, Abner, Erik, Emdin, Connor A., Gobeil, Émilie, Taba, Nele, Haas, Mary E., Perrot, Nicolas, Manikpurage, Hasanga D., Gagnon, Éloi, Bourgault, Jérôme, St-Amand, Alexis, Couture, Christian, Mitchell, Patricia L., Bossé, Yohan, Mathieu, Patrick, Vohl, Marie-Claude, Tchernof, André, Thériault, Sébastien, Khera, Amit V., Esko, Tõnu, Arsenault, Benoit J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606899/ https://www.ncbi.nlm.nih.gov/pubmed/34841290 http://dx.doi.org/10.1016/j.xcrm.2021.100437 |
Ejemplares similares
-
Electronic Health Record-Based Genome-Wide Meta-Analysis Identifies New Susceptibility Loci for Non-Alcoholic Fatty Liver Disease
por: Ghodsian, Nooshin, et al.
Publicado: (2021) -
Genome-Wide Meta-Analysis and Mendelian Randomization Identify Early Biomarkers of Non-Alcoholic Fatty Liver Disease
por: Gobeil, Emilie, et al.
Publicado: (2021) -
Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases
por: Gagnon, Eloi, et al.
Publicado: (2022) -
Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease
por: Gobeil, Émilie, et al.
Publicado: (2022) -
Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
por: Gagnon, Eloi, et al.
Publicado: (2023)